Editorials |
From the Department of Physiology & Biophysics, University of Washington, Seattle.
Correspondence to Luis F. Santana, Department of Physiology & Biophysics, University of Washington, Box 357290, Seattle, WA 98195. E-mail santana{at}u.washington.edu
See related article, pages 733–742
Key Words: arrhythmias calcium L-type Ca2+ channels Ito
| Introduction |
|---|
|
|
|---|
| Step 1: Defining and Understanding the Problem |
|---|
|
|
|---|
subunit of L-type Ca2+ channels (Cav1.2) underlie decreased ICa function during atrial tachycardia and fibrillation. Like atrial myocytes, long-term tachycardia could also alter the waveform of the AP of ventricular myocytes and has been found to cause heart failure in canine.8 Chronic tachycardia decreases the amplitude of the transient outward K+ current (Ito), which alters phase 1 of the ventricular AP. This has the potential of altering excitation–contraction coupling9,10 and increasing arrhythmogenesis11 during heart failure. Rate-dependent decreases in Ito are caused, at least in part, by downregulation of transcript and protein levels of Kv4.312 channel subunits in human and canine ventricular myocytes.
As noted above, Xiao et al1 and Qi et al2 addressed a fundamental issue brought up by these findings: what are the signaling mechanisms that translate increased heart rate into downregulation of Cav1.2 and Kv4.3 genes in atrial and ventricular myocytes? Multiple lines of evidence suggest an answer to this important question. First, increasing AP firing rate increases [Ca2+]i in cardiac myocytes.13 Second, there are putative NFAT-binding sites in the promoter region of Cav1.2 and Kv4.3 genes.14,15 Third, activation of NFATc3 downregulates Ito in mouse ventricular myocytes.14,15 On the basis of these findings, Xiao et al1 and Qi et al2 hypothesized that rate-dependent changes in [Ca2+]i, as well as the activity of the Ca2+-dependent phosphatase calcineurin and the transcription factor NFATc3, could form part of a signaling cascade that downregulates Cav1.2 and Kv4.3 expression in atrial and ventricular myocytes during tachycardia.
| Step 2: Devising a Plan |
|---|
|
|
|---|
| Step 3: Carrying Out the Plan |
|---|
|
|
|---|
| Step 4: Looking Back, Examination of the Results Obtained |
|---|
|
|
|---|
As with any good study, the impact of the work Xiao et al1 and Qi et al2 is not limited to the questions they answered, but the questions they raised. For example, whereas Xiao et al,1 as well as others,14,15 have linked NFAT activation to downregulation of Kv4.3 in adult ventricular myocytes, a recent study suggests that NFAT could upregulate Kv4 channels in neonatal ventricular myocytes.18 How could these seemingly contradictory findings be reconciled? One possibility is that NFAT associates with other transcription factors and binding partners, and whether NFAT upregulate or downregulate the expression of specific genes would depend on the molecular identity of the proteins this transcription factor associates with. Another question brought up by the work of Qi et al2 is why does NFATc3/c4 activation decreases Cav1.2 in atrial but not in ventricular myocytes? Future studies should address these important issues.
In addition to inducing Kv4.3 and Cav1.2 channel downregulation, activation of calcineurin/NFAT signaling causes hypertrophy.19 Inhibition of calcineurin decreases ventricular hypertrophy by up to 40% after myocardial infarction.20,21 In contrast, Xiao et al1 and Qi et al2 suggest that preventing calcineurin and NFAT activation completely prevents rate-dependent Ito and ICa remodeling. Given that calcineurin/NFAT inhibition only partially blocks the development of hypertrophy, whereas Ito and ICa downregulation is completely prevented, it is intriguing to speculate that there may be less redundancy in the pathways leading to Kv4.3 and Cav1.2 downregulation in atrial and ventricular myocytes.
Let us end by highlighting a central tenet in the problem-solving approach of Polya: that analyzing how others solved a particular problem could help answering new questions in the future. With this in mind, the work by Xiao et al1 and Qi et al2 forms part of the emerging field of excitation-transcription coupling.22 The approaches and concepts developed by Xiao et al1 and Qi et al2 represent an important contribution to this field and, if one is to follow the advice of Polya, should help to unravel and clearly define signaling pathways responsible for the regulation of the expression and function of voltage-gated ion channels in excitable cells under physiological and pathophysiological conditions.
| Acknowledgments |
|---|
Supported by NIH grant HL085686. L.F.S. is an Established Investigator of the American Heart Association.
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Qi XY, Yeh YH, Xiao L, Burstein B, Maguy A, Chartier D, Villenueve LR, Brundel BJJM, Dobrev D, Nattel S. Cellular signaling underlying atrial tachicardia remodeling of L-type calcium current. Circ Res. 2008; published online August 21, 2008.
3. Polya G. How to Solve It. 2nd ed. Princeton, NJ: Princeton University Press; 1957.
4. Van Wagoner DR, Nerbonne JM. Molecular basis of electrical remodeling in atrial fibrillation. J Mol Cell Cardiol. 2000; 32: 1101–1117.[CrossRef][Medline] [Order article via Infotrieve]
5. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation. 1997; 96: 3710–3720.
6. Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 1999; 85: 428–436.
7. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res. 1997; 81: 512–525.
8. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 1996; 78: 262–273.
9. Harris DM, Mills GD, Chen X, Kubo H, Berretta RM, Votaw VS, Santana LF, Houser SR. Alterations in early action potential repolarization causes localized failure of sarcoplasmic reticulum Ca2+ release. Circ Res. 2005; 96: 543–550.
10. Sah R, Ramirez RJ, Backx PH. Modulation of Ca2+ release in cardiac myocytes by changes in repolarization rate: role of phase-1 action potential repolarization in excitation-contraction coupling. Circ Res. 2002; 90: 165–173.
11. Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyen-Tran VT, Gu Y, Ikeda Y, Chu PH, Ross J, Giles WR, Chien KR. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of Ito and confers susceptibility to ventricular tachycardia. Cell. 2001; 107: 801–813.[CrossRef][Medline] [Order article via Infotrieve]
12. Zicha S, Xiao L, Stafford S, Cha TJ, Han W, Varro A, Nattel S. Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts. J Physiol. 2004; 561: 735–748.
13. Antoons G, Mubagwa K, Nevelsteen I, Sipido KR. Mechanisms underlying the frequency dependence of contraction and [Ca(2+)](i) transients in mouse ventricular myocytes. J Physiol. 2002; 543: 889–898.
14. Rossow CF, Dilly KW, Santana LF. Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart. Circ Res. 2006; 98: 1306–1313.
15. Rossow CF, Minami E, Chase EG, Murry CE, Santana LF. NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction. Circ Res. 2004; 94: 1340–1350.
16. Layne J, Werner ME, Hill-Eubanks D, Nelson MT. NFATc3 regulates BK channel function in murine urinary bladder smooth muscle. Am J Physiol Cell Physiol. 2008; 295: C611–C623.
17. Nieves-Cintrón M, Amberg GC, Nichols CB, Molkentin JD, Santana LF. Activation of NFATc3 down-regulates the β1 subunit of large conductance, calcium-activated K+ channels in arterial smooth muscle and contributes to hypertension. J Biol Chem. 2007; 282: 3231–3240.
18. Gong N, Bodi I, Zobel C, Schwartz A, Molkentin JD, Backx PH. Calcineurin increases cardiac transient outward K+ currents via transcriptional up-regulation of Kv4.2 channel subunits. J Biol Chem. 2006; 281: 38498–38506.
19. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998; 93: 215–228.[CrossRef][Medline] [Order article via Infotrieve]
20. Deng L, Huang B, Qin D, Ganguly K, El-Sherif N. Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling. J Cardiovasc Electrophysiol. 2001; 12: 1055–1061.[CrossRef][Medline] [Order article via Infotrieve]
21. van Rooij E, Doevendans PA, Crijns HJ, Heeneman S, Lips DJ, van Bilsen M, Williams RS, Olson EN, Bassel-Duby R, Rothermel BA, De Windt LJ. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circ Res. 2004; 94: e18–e26.[CrossRef][Medline] [Order article via Infotrieve]
22. Atar D, Backx PH, Appel MM, Gao WD, Marban E. Excitation-transcription coupling mediated by zinc influx through voltage-dependent calcium channels. J Biol Chem. 1995; 270: 2473–2477.
Related Article:
Circ. Res. 2008 103: 733-742.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |